193 related articles for article (PubMed ID: 38068934)
1. Metformin Suppresses Stemness of Non-Small-Cell Lung Cancer Induced by Paclitaxel through FOXO3a.
Tang Z; Zhang Y; Yu Z; Luo Z
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38068934
[TBL] [Abstract][Full Text] [Related]
2. Baicalein increases the expression and reciprocal interplay of RUNX3 and FOXO3a through crosstalk of AMPKα and MEK/ERK1/2 signaling pathways in human non-small cell lung cancer cells.
Zheng F; Wu J; Zhao S; Luo Q; Tang Q; Yang L; Li L; Wu W; Hann SS
J Exp Clin Cancer Res; 2015 May; 34(1):41. PubMed ID: 25948105
[TBL] [Abstract][Full Text] [Related]
3. Caveolin-1 is essential for metformin inhibitory effect on IGF1 action in non-small-cell lung cancer cells.
Salani B; Maffioli S; Hamoudane M; Parodi A; Ravera S; Passalacqua M; Alama A; Nhiri M; Cordera R; Maggi D
FASEB J; 2012 Feb; 26(2):788-98. PubMed ID: 22038047
[TBL] [Abstract][Full Text] [Related]
4. Potential monoamine oxidase A inhibitor suppressing paclitaxel-resistant non-small cell lung cancer metastasis and growth.
Yang X; Zhao D; Li Y; Li Y; Cui W; Li Y; Li H; Li X; Wang D
Thorac Cancer; 2020 Oct; 11(10):2858-2866. PubMed ID: 32875729
[TBL] [Abstract][Full Text] [Related]
5. NLK functions to maintain proliferation and stemness of NSCLC and is a target of metformin.
Suwei D; Liang Z; Zhimin L; Ruilei L; Yingying Z; Zhen L; Chunlei G; Zhangchao L; Yuanbo X; Jinyan Y; Gaofeng L; Xin S
J Hematol Oncol; 2015 Oct; 8():120. PubMed ID: 26503334
[TBL] [Abstract][Full Text] [Related]
6. Multiplicity of acquired cross-resistance in paclitaxel-resistant cancer cells is associated with feedback control of TUBB3 via FOXO3a-mediated ABCB1 regulation.
Aldonza MB; Hong JY; Alinsug MV; Song J; Lee SK
Oncotarget; 2016 Jun; 7(23):34395-419. PubMed ID: 27284014
[TBL] [Abstract][Full Text] [Related]
7. p38 MAPK-induced MDM2 degradation confers paclitaxel resistance through p53-mediated regulation of EGFR in human lung cancer cells.
Park SH; Seong MA; Lee HY
Oncotarget; 2016 Feb; 7(7):8184-99. PubMed ID: 26799187
[TBL] [Abstract][Full Text] [Related]
8. Shikonin suppresses NEAT1 and Akt signaling in treating paclitaxel-resistant non-small cell of lung cancer.
Zang F; Rao Y; Zhu X; Wu Z; Jiang H
Mol Med; 2020 Apr; 26(1):28. PubMed ID: 32268876
[TBL] [Abstract][Full Text] [Related]
9. SOX2 regulates paclitaxel resistance of A549 non‑small cell lung cancer cells via promoting transcription of ClC‑3.
Huang Y; Wang X; Hu R; Pan G; Lin X
Oncol Rep; 2022 Oct; 48(4):. PubMed ID: 36069232
[TBL] [Abstract][Full Text] [Related]
10. Circ_0011292 knockdown mitigates progression and drug resistance in PTX-resistant non-small-cell lung cancer cells by regulating miR-433-3p/CHEK1 axis.
Jin M; Zhang F; Li Q; Xu R; Liu Y; Zhang Y
Thorac Cancer; 2022 May; 13(9):1276-1288. PubMed ID: 35348291
[TBL] [Abstract][Full Text] [Related]
11. Nootkatone, an AMPK activator derived from grapefruit, inhibits KRAS downstream pathway and sensitizes non-small-cell lung cancer A549 cells to adriamycin.
Hung LVM; Moon JY; Ryu JY; Cho SK
Phytomedicine; 2019 Oct; 63():153000. PubMed ID: 31280139
[TBL] [Abstract][Full Text] [Related]
12. Blocking circ_0010235 suppresses acquired paclitaxel resistance of non-small cell lung cancer by sponging miR-512-5p to modulate FAM83F expression.
Li Y; Ma Z; Luo M; Liang R
Anticancer Drugs; 2022 Nov; 33(10):1024-1034. PubMed ID: 36206095
[TBL] [Abstract][Full Text] [Related]
13. Combination of Solamargine and Metformin Strengthens IGFBP1 Gene Expression Through Inactivation of Stat3 and Reciprocal Interaction Between FOXO3a and SP1.
Tang Q; Zheng F; Wu J; Xiao Q; Li L; Hann SS
Cell Physiol Biochem; 2017; 43(6):2310-2326. PubMed ID: 29073599
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel-induced nuclear translocation of FOXO3a in breast cancer cells is mediated by c-Jun NH2-terminal kinase and Akt.
Sunters A; Madureira PA; Pomeranz KM; Aubert M; Brosens JJ; Cook SJ; Burgering BM; Coombes RC; Lam EW
Cancer Res; 2006 Jan; 66(1):212-20. PubMed ID: 16397234
[TBL] [Abstract][Full Text] [Related]
15. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
[TBL] [Abstract][Full Text] [Related]
16. AMP-activated protein kinase re-sensitizes A549 to paclitaxel via up-regulating solute carrier organic anion transporter family member 1B3 expression.
Jiang S; Luo Y; Zhan Z; Tang Z; Zou J; Ying Y; Lin H; Huang D; Luo L
Cell Signal; 2022 Mar; 91():110215. PubMed ID: 34920124
[TBL] [Abstract][Full Text] [Related]
17. Hsa_circ_0092887 targeting miR-490-5p/UBE2T promotes paclitaxel resistance in non-small cell lung cancer.
Wang L; Zhang Z; Tian H
J Clin Lab Anal; 2023 Jan; 37(1):e24781. PubMed ID: 36550019
[TBL] [Abstract][Full Text] [Related]
18. The tumor suppressor gene TUSC2 (FUS1) sensitizes NSCLC to the AKT inhibitor MK2206 in LKB1-dependent manner.
Meng J; Majidi M; Fang B; Ji L; Bekele BN; Minna JD; Roth JA
PLoS One; 2013; 8(10):e77067. PubMed ID: 24146957
[TBL] [Abstract][Full Text] [Related]
19. Shikonin induces apoptosis of lung cancer cells via activation of FOXO3a/EGR1/SIRT1 signaling antagonized by p300.
Jeung YJ; Kim HG; Ahn J; Lee HJ; Lee SB; Won M; Jung CR; Im JY; Kim BK; Park SK; Son MJ; Chung KS
Biochim Biophys Acta; 2016 Nov; 1863(11):2584-2593. PubMed ID: 27452907
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Anti-Metastatic Potential of the Combination of Fisetin with Paclitaxel on A549 Non-Small Cell Lung Cancer Cells.
Klimaszewska-Wiśniewska A; Hałas-Wiśniewska M; Grzanka A; Grzanka D
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]